170 related articles for article (PubMed ID: 3038518)
21. [Structural-functional organization of the SV40 virus chromosome. II. Characteristics of viral genome containing deletion in the regulatory region].
Nedospasov SA; Shakhov AN; Sali R
Mol Biol (Mosk); 1984; 18(4):1090-8. PubMed ID: 6095024
[TBL] [Abstract][Full Text] [Related]
22. Multiple sequence motifs are involved in SV40 enhancer function.
Zenke M; Grundström T; Matthes H; Wintzerith M; Schatz C; Wildeman A; Chambon P
EMBO J; 1986 Feb; 5(2):387-97. PubMed ID: 3011406
[TBL] [Abstract][Full Text] [Related]
23. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
24. The SV40 enhancer influences viral late transcription in vitro and in vivo but not on replicating templates.
Shaw PE; Bohmann D; Sergeant A
EMBO J; 1985 Dec; 4(12):3247-52. PubMed ID: 3004947
[TBL] [Abstract][Full Text] [Related]
25. Structure, DNaseI hypersensitivity and expression of integrated papilloma virus in the genome of HeLa cells.
Lazo PA
Eur J Biochem; 1987 Jun; 165(2):393-401. PubMed ID: 2439332
[TBL] [Abstract][Full Text] [Related]
26. A cellular protein binds to a conserved sequence in the adenovirus type 2 enhancer.
Barrett P; Clark L; Hay RT
Nucleic Acids Res; 1987 Mar; 15(6):2719-35. PubMed ID: 3031610
[TBL] [Abstract][Full Text] [Related]
27. Transcriptional enhancer factor (TEF)-1 and its cell-specific co-activator activate human papillomavirus-16 E6 and E7 oncogene transcription in keratinocytes and cervical carcinoma cells.
Ishiji T; Lace MJ; Parkkinen S; Anderson RD; Haugen TH; Cripe TP; Xiao JH; Davidson I; Chambon P; Turek LP
EMBO J; 1992 Jun; 11(6):2271-81. PubMed ID: 1318197
[TBL] [Abstract][Full Text] [Related]
28. Identification of early proteins of the human papilloma viruses type 16 (HPV 16) and type 18 (HPV 18) in cervical carcinoma cells.
Seedorf K; Oltersdorf T; Krämmer G; Röwekamp W
EMBO J; 1987 Jan; 6(1):139-44. PubMed ID: 3034571
[TBL] [Abstract][Full Text] [Related]
29. Repression of the immunoglobulin heavy chain enhancer by the adenovirus-2 E1A products.
Hen R; Borrelli E; Chambon P
Science; 1985 Dec; 230(4732):1391-4. PubMed ID: 2999984
[TBL] [Abstract][Full Text] [Related]
30. Transcriptional activity of human papillomavirus type 31b enhancer is regulated through synergistic interaction of AP1 with two novel cellular factors.
Kyo S; Tam A; Laimins LA
Virology; 1995 Aug; 211(1):184-97. PubMed ID: 7645210
[TBL] [Abstract][Full Text] [Related]
31. The human cytomegalovirus immediate early enhancer-promoter is responsive to activation by the adenovirus-5 13S E1A gene.
Olive DM; al-Mulla W; Simsek M; Zarban S; al-Nakib W
Arch Virol; 1990; 112(1-2):67-80. PubMed ID: 2142416
[TBL] [Abstract][Full Text] [Related]
32. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines.
Baker CC; Phelps WC; Lindgren V; Braun MJ; Gonda MA; Howley PM
J Virol; 1987 Apr; 61(4):962-71. PubMed ID: 3029430
[TBL] [Abstract][Full Text] [Related]
33. Silencing of human immunodeficiency virus long terminal repeat expression by an adenovirus E1a mutant.
Ventura AM; Arens MQ; Srinivasan A; Chinnadurai G
Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1310-4. PubMed ID: 2137611
[TBL] [Abstract][Full Text] [Related]
34. General repression of enhanson activity by the adenovirus-2 E1A proteins.
Rochette-Egly C; Fromental C; Chambon P
Genes Dev; 1990 Jan; 4(1):137-50. PubMed ID: 2155159
[TBL] [Abstract][Full Text] [Related]
35. An enhancer sequence from bovine papilloma virus DNA consists of two essential regions.
Weiher H; Botchan MR
Nucleic Acids Res; 1984 Mar; 12(6):2901-16. PubMed ID: 6324133
[TBL] [Abstract][Full Text] [Related]
36. Epidermal growth factor induction of human papillomavirus type 16 E6/E7 MRNA in tumor cells involves two AP-1 binding sites in the viral enhancer.
Peto M; Tolle-Ersü I; Kreysch HG; Klock G
J Gen Virol; 1995 Aug; 76 ( Pt 8)():1945-58. PubMed ID: 7636475
[TBL] [Abstract][Full Text] [Related]
37. Identification and functional analysis of sequence rearrangements in the long control region of human papillomavirus type 16 Af-1 variants isolated from Ugandan penile carcinomas.
Tornesello ML; Buonaguro FM; Buonaguro L; Salatiello I; Beth-Giraldo E; Giraldo G
J Gen Virol; 2000 Dec; 81(Pt 12):2969-2982. PubMed ID: 11086128
[TBL] [Abstract][Full Text] [Related]
38. The chromatin structure of the long control region of human papillomavirus type 16 represses viral oncoprotein expression.
Stünkel W; Bernard HU
J Virol; 1999 Mar; 73(3):1918-30. PubMed ID: 9971771
[TBL] [Abstract][Full Text] [Related]
39. Constitutive and steroid hormone regulated transcriptional enhancer elements in the genome of the human papilloma virus type 16, which is associated with neoplasia of the cervix.
Klock G; Gloss B; Bernard HU
Cancer Detect Prev; 1988; 12(1-6):23-9. PubMed ID: 2846169
[TBL] [Abstract][Full Text] [Related]
40. Characterization of a nuclear factor, papilloma enhancer binding factor-1, that binds the long control region of human papillomavirus type 16 and contributes to enhancer activity.
Cuthill S; Sibbet GJ; Campo MS
Mol Carcinog; 1993; 8(2):96-104. PubMed ID: 8397799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
